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Between September 1976 and September 1993, 270 patients underwent aortic root 
replacement a our institution. Two hundred fifty-two patients underwent a Bentall 
composite graft repair and 18 patients received a cryopreserved homograft aortic root. 
One hundred eighty-seven patients had a Marfan aneurysm of the ascending aorta (41 
with dissection) and 53 patients had an aneurysm resulting from nonspecific medial 
degeneration (17 with dissection). These 240 patients were considered to have annu- 
loaortic ectasia. Thirty patients were operated on for miscellaneous lesions of the aortic 
root. Thirty-day mortality for the overall series of 270 patients was 4.8% (13/270). There 
was no 30-day mortality among 182 patients undergoing elective root replacement for 
annuloaortic ectasia without dissection. Thirty-six of the 270 patients having root 
replacement also had mitral valve operations. There was no hospital mortality for aortic 
root replacement in these 36 patients, but there were seven late deaths. Twenty-two 
patients received a cryopreserved homograft aortic root; 18 of these were primary root 
replacements and four were repeat root replacements for late endocarditis. One early 
death and two late deaths occurred in this group. Actuarial survival for the overall group 
of 270 patients was 73% at 10 years. In a multivariate analysis, only poor New Year 
Heart Association dass (Il] and IV), non-Marfan status, preoperative dissection, and 
male gender emerged as significant predictors of early or late death. Endocarditis was 
the most common late complication (14 of 256 hospital survivors) and was optimally 
treated by root replacement with a cryopreserved aortic homograft. Late problems with 
the part of the aorta not operated onoccur with moderate frequency; careful follow-up 
of the distal aorta is critical to long-term survival. (J THORAC CARDIOVASC SURG 1995; 
109:536-45) 
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R eplacement of the aortic root, first performed by Bentall and DeBono I in 1968, has been applied 
to a variety of aortic diseases. Although early results 
of this procedure have been described with particu- 
lar focus on patient subsets, such as those with the 
Marfan syndrome, few broad overviews of the pro- 
cedure including risk factor analysis and examina- 
tion of long-term results have been published. 2-4 
This report summarizes our experience with all 
patients (with and without the Marfan syndrome) 
undergoing aortic root replacement at our institu- 
tion over the past 18 years. 
Patients and methods 
Patient selection. All patients undergoing aortic root e-
placement between September 1976 and September 1993 
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are included in this report. Patients were identified from a 
compnterized patient registry, operative log books, and office 
records. Data were collected retrospectively from operative 
records, hospital charts, nd clinic follow-up notes. Late 
follow-up data were obtained from clinie records and direct 
contact with patients andtheir primary physicians. 
The majority of patients in this series (187/270; 69%) 
had the Marfan syndrome and aneurysm of the ascending 
aorta (Table I); this reflects a referral pattern in our 
institution resulting from the Center for Medical Genetics 
of The Johns Hopkins Hospital, which sees a large 
number of patients with Marfan syndrome annually. 
Operative teehnique. Two hundred fifty-two of the 270 
patients undergoing aortic root replacement had a com- 
posite graft placed by means of the Bentall technique or 
its modification. 1 The other 18 patients underwent root 
replacement with a cryopreserved aortic homograft. 
Early in the series, the Bentall procedure included 
wrapping the aortic aneurysm wall around the composite 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 109, Number 3 
Gott et al. 537 
graft for hemostasis; the first 87 patients with Marfan 
syndrome inthe series had aneurysm wraps. After a report 
in i986 by Kouchoukos, Marshall, and Wedige-Stecher s 
on late complications of the wrap, the technique was 
discontinued. Also early in the series, direct anastomosis 
of the coronary arteries to the Dacron graft was per- 
formed without excision of the coronary arteries from the 
aortic wall. After description of the Cabrol interposition 
graft, 6this type of graft was used with moderate frequency 
commencing August 1986 but was discontinued January 
1989 after compression of the left coronary ostium was 
observed in one case. 
Between 1976 and May 1986, Björk-Shiley composite 
grafts (Shiley, Inc., Irvine, Calif.) were used. Initially, 
these grafts were fabricated at the operating table from a 
prosthetic valve and a Dacron tube. Since May 1986, the 
St. Jude Medical composite graft valve (St. Jude Medical, 
Inc., St. Paul, Minn.) has been preferred. 
Standard hypothermic (28 ° to 30 ° C) cardiopulmonary 
bypass techniques were used. Myocardial protection con- 
sisted of simple antegrade administration f crystalloid 
potassium cardioplegic solution (Stanford solution, 1 L) 
and maintenance of myocardial hypothermia by continu- 
ous topical 4°C saline solution given at a rate of 100 
ml/min. 
Our operative technique has been described in earlier 
publications.7, 8 If the coronary ostia have migrated more 
than 2 cm from the aortic anulus, mattress utures are 
placed in everting fashion; if the ostia are relatively low 
lying, mattress sutures are placed from below the anulus, 
as described by Helseth and colleagues. 9 Although we still 
prefer direct anastomosis of the coronary arteries to the 
Dacron graft without excision of the coronaries from the 
aortic wall, if either coronary ostium is low in the aorta, it 
is excised, mobilized, and anastomosed slightly higher on 
the composite graft. After completion of the two coronary 
anastomoses, the distal ascending aorta is transected and 
anastomosed to the composite graft with continuous 3-0 
polypropylene. 
Homografts were implanted in a manner similar to 
composite grafts, except hat a thin strip of Teflon fer was 
occasionally used to reinforce the homograft side of the 
proximal anastomosis. 
Of the 270 patients having root replacement, 28 (28/ 
270; 10%) required hypothermic circulatory arrest to 
permit partial resection of the aortic arch or facilitate 
anastomosis of the composite graft to the proximal arch. 
Statistical methods. Survival and event-free curves 
were calculated by the Kaplan-Meier method. Univariate 
analysis was performed by the Mantel-Cox method and 
the multivariate analysis by the Cox proportional hazards 
method. Survival data are presented with standard error 
of the estimate. Statistical computations were made with 
the use of the BMDP statistical software package (BMDP 
Software, Los Angeles, Calif.). 
Results 
Operative data were available for all patients. 
Follow-up data were available for 94% of 256 
hospital survivors at a mean interval of 4 years after 
the operation. 
Preoperative patient characteristics. Mean pa- 
tient age was 38.3 years. Mean age of the patients 
with the Marfan syndrome was 32.8 years, and for 
those with non-Marfan medial degeneration it was 
49.3 years. The 30 patients with other miscellaneous 
diagnoses had a mean age of 53.0 years. Two 
hundred three of the 270 patients were male (203/ 
270; 75%). Eighty-eight patients were in New York 
Heart Asso¢iation (NYHA) functional dass I 
(33%), 75 (28%) were in class II, 54 (20%) were in 
dass III, and 43 (16%) were in class IV. NYHA 
functional class information was not available in 10 
patients (3%). 
The various pathologic lesions for which root 
replacement was performed are shown in Table I. 
The majority of patients in this series had a Marfan 
aneurysm of the ascending aorta (187/270; 69%). 
Fifty-three patients (53/270; 20%) had aortic root 
replacement for aneurysm caused by nonspecific 
medial degeneration but not associated with the 
Marfan syndrome. Thus 240 patients (240/270; 
89%) had annuloaortic ectasia s the primary patho- 
logic lesion. The remaining 30 patients (30/270; 
11%) had miscellaneous diagnoses: prosthetic endo- 
carditis (n = 15), atherosclerotic aneurysm (n = 8), 
aortic injury from crossclamping (n = 3), arteritis 
(n = 2), and Ehlers-Danlos yndrome (n = 2). Of 
the 15 cases of prosthetic endocarditis, 11 were 
infections of aortic valve prostheses, 2 were sleeve 
graft infections, and 2 were composite graft infec- 
tions. Thirty-six of the 270 patients treated by root 
replacement also underwent mitral valve operations 
and 13 underwent coronary artery bypass for ob- 
structive disease. 
Operative results. Thirty-day mortality for the 
series of 270 patients was 4.8% (13/270; Table II). 
However, no early deaths occurred among the 182 
patients undergoing root replacement for annu- 
loaortic ectasia aneurysm without dissection; this 
group included 146 patients with Marfan syndrome 
and 36 patients with other types of medial degener- 
ation. Among the 240 patients with annuloaortic 
ectasia with or without dissection, there were six 
early deaths (2.5%). Causes of death, both early and 
late after operation, are detailed in Table II. Low 
cardiac output was the most common cause of death 
early after operation. In this report, the terms 30-day 
mortality and early mortality are used interchange- 
ably. 
In 63 of the 270 patients dissection of the ascend- 
ing aorta was documented uring the operation 
(63/270; 23%). The distribution of acute versus 
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Table I. Aortic root replacement in 270 patients at The .lohns Hopkins Hospital 
Annuloaortic ectasia (patients) 
Other medial 











146 36 182 10" 192 
41 17 58 5 63 
16 3 19 
4 2 6 
3 5 8 
18 7 25 












*Atherosclerotic aneurysm, n = 7; arteritis, n = 2; Ehlers-Danlos, n = 1. 
tEhlers-Danlos. 
~:Postoperative aortic lamp injury and atherosclerotic aneurysm. 
§Postoperative aortic lamp injury, n = 2. 
[[After aortic valve replacement, n = 11; after composite graft, n = 2; after sleeve graft, n = 2. 
Table II. Causes o f  death after aortic root replacement 
Other medial 
Marfan (n = 187)  degeneration (n = 53) Total mortality 
Aneurysm Dissection Aneurysm Dissection Miscellaneous 
Causes of death (n = 146) (n = 41) (n = 36) (n = 17) (n = 30) 30 day Late 
Low output (operating room) 2* 1" 3* 6 
Multiorgan failure 1 1 4* 4 2 
Hemorrhage 1 * 1 
Neurologic injury, circulatory arrest 1" 1 
Gangrenous gallbladder 1 1 
Arrhythmiat 6 i* 1 6 
Pulmonary sepsis 1 1 
Drug overdose 1 1 
Composite graft endocarditis 2 1 1 1 i 6 
Rupture of distal aorta 1 2 3 
Coronary dehiseence 1 1 
Secondary tolate thoracoabdominal 1 1 2 
resection$ 
Unknown 1 3 1 5 
Total 11 11 4 6 9 13 28 
*Thirty-day mortality. 
tKnown or presumed. 
~:A patient with Maffan disease and DeBakey t pe I dissection died 4 years after a composite graft operation after a thoracoabdominal procedure; a patient 
with Ehlers-Danlos syndrome died 5 years after a composite graft operation after a thoracoabdominal procedure. 
chronic dissection and the DeBakey type are pre- 
sented in Table I. In the 63 patients with dissection, 
mean aortic diameter at the sinus level was 7.8 cm, 
in contrast o 6.7 cm in those without dissection. 
Forty-one of the 187 patients with the Marfan 
disease had ascending aortic dissection (41/187; 
22%); mean aortic diameter in this group was 7.6 cm 
versus 6.7 cm for those without dissection. Of note, 
10 patients with the Marfan syndrome had dissec- 
tion in an aorta smaller than 6.5 cm. Two of the 41 
patients who had the Marfan syndrome with rup- 
tured aorta and pericardial tamponade died during 
the operation of low eardiac output; both were 
mor ibund on hospital admission. 
Seventeen patients with non-Marfan medial de- 
generation had dissections, five acute and 12 
chronie. Four  early deaths occurred among these 17 
patients (see Table II). 
Thirty-six of the 270 patients undergoing root 
replacement also had mitral valve operations (Table 
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III). All of these patients were in the annuloaortic 
ectasia group. Thirty-two mitral procedures were 
concomitant with root replacement, and four were 
performed at a separate operation. There were 26 
mitral repairs and 10 mitral replacements with pros- 
theses. No hospital deaths occurred as a result of 
aortic root replacement in these 36 patients. 
The highest operative mortality occurred in the 
group with miscellaneous diagnoses (see Tables I 
and II). Nine of these 30 patients died (9/30; 30%), 
typically of low cardiac output or multiple organ 
failure. Half of the miscellaneous group (15/30) had 
endocarditis; four early deaths occurred among 
these 15 patients (4/15; 27%), all as a result of low 
cardiac output or multiple organ failure and all in 
patients with infected aortic prostheses. Of 15 pa- 
tients undergoing root replacement for prosthetic 
endocarditis, 11 received a cryopreserved homo- 
graft. One early death occurred in this group as a 
result of multiple organ failure. Seven patients with 
the Marfan syndrome (two adults and five children) 
also received homograft roots as their primary pro- 
cedure, mainly to avoid anticoagulation associated 
with mechanical prostheses; no early deaths oc- 
curred in this group. 
Late results. A total of 28 late deaths have oc- 
curred among the 256 hospital survivors (see Table 
II). Twenty of these late deaths fall into four major 
categories: arrhythmia (n = 6), composite graft 
endocarditis (n = 6), unknown (n = 5), and rupture 
of the unoperated aorta distal to the composite graft 
(n = 3). The remaining 11 deaths were ffom diverse 
causes. Only one death resulted from late dehis- 
cence of a coronary artery-composite graft anasto- 
mosis. 
Fig. 1 depicts actuarial survival for the overall 
group of 270 patients. Survival was 82% at 5 years, 
73% at 10 years, and 67% at 14 years. 
Risk factor analysis. Multiple patient- and pro- 
cedure-related variables were screened by univari- 
ate and subsequent multivariate analysis as potential 
risk factors for early or late death. These variables 
included preoperative NYHA functional class, gen- 
der, age, presence of aortic dissection, Marfan syn- 
drome, race, use of hypothermic circulatory arrest, 
type of graft used for root replacement, urgency of 
operation, mitral valve operation, coronary artery 
disease, previous root surgery, and era of operation. 
In a multivariate analysis, only poor NYHA class 
(III or IV), non-Marfan status, preoperative dissec- 
tion, and male gender emerged as significant inde- 
pendent predictors of early or late death (Figs. 2, 3, 
Table III. Mitral valve operations among 240 
patients undergoing aortic root replacement for 
annuloaortic ectasia 
No. of Late 
patients mortality 
Marfan (n = 187) 
Concomitant with root 30 
replacement 
Annular repair 24* 4§ 
MVR 6 
Not concomitant with 4 
root replacement 
Annular repair I t  
MVR 3 211 
Other medical degenera- 
tion (n = 53) 
Concomitant with root 2 
replacement 
Annular repair 1:~ 
MVR 1 1¶ 
Total 36 7 
*Twenty-three patients had annular ring and one patient had annuloplasty. 
tAnnular ing. 
~:Annuloplasty. 
§Two patients, presumed arrhythmia t 4 and 5 years; one patient, 
presumed issection and rupture of descending thoracic aorta at 3 years; 
one patient, cause unknown at 10 months (preoperative ejection fraction 
was 10%). 
IkOne patient, presumed arrhythmia t 20 months; one patient, porcine 
mitral valve placed 2 years before composite graft and St. Jude Medica| 
mitral valve placed 7 years after composite graft. Patient had chronic stable 
dissection of abdominal aorta and chronic atrial fibrillation. Died of 
unknown cause 9 years after composite repair. 
¶Endocarditis at 2 years. 
and 4 and Table IV). The impact of type I and II 
dissections on survival is depicted in Fig. 4; survival 
at 5 yeärs was 87% without dissection but was 79% 
and 55% for type II and Type I dissections, respec- 
tively. At 10 years, survivals dropped to 81%, 66%, 
and 45% for patients without dissection and for 
patients with type II and type I dissections, respec- 
tively. 
Endocarditis. Endocarditis was the most common 
late complication after root replacement. Fourteen of 
the 256 hospital survivors had late endocarditis (14/ 
256; 5%). Seven were treated nonoperatively and two 
survived. Two other patients with infected prosthe- 
ses underwent repeat composite graft placement; 
one died and the other required a third and finally 
successful root replacement with an aortic ho- 
mograft. Three additional patients received ho- 
mografts for infected composite grafts and two 
survived. All four homografts remained free of 
endocarditis and functioned satisfactorily, but one 
540 Gott et al. 
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Fig. 1. Actuarial survival after aortic root replacement in 270 patients. 
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Fig. 2. Actuarial survival bypreoperative NYHA classification. 
patient died of a drug overdose 10 months after the 
operation. 
Freedom from endocarditis in the overall series 
was 93%, 88%, and 88% at 5, 10, and 14 years, 
respectively (Fig. 5). 
Other late complications. Despite use of the aor- 
tic wrap during the first 12 years of this operative 
series, only one late death resulting from coronary 
anastomotic dehiscence has occurred. However, five 
other patients had late coronary dehiscence and 
underwent successful repair. Actuarial freedom 
from coronary dehiscence was 93% at 10 years. 
Although the Cabrol interposition graft was discon- 
tinued in January !989 because of intraoperative 
compression of the left coronary ostium in one 
patient, no late complications have resulted from 
this particular technique. 
Fourteen patients required a subsequent thoracic 
or abdominal aortic procedure for dissection or 
progressive dilatation; nine of these 14 patients are 
long-term survivors. Thus actuarial freedom from 
reoperation on the residual aorta was 86% at 10 
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Fig. 3. Influence of Marfan disease on actuarial survival. 
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Fig. 4. Influence of preoperative dissection on actuarial survival. 
years (Fig. 6). Three patients also had late aortic 
rupture; freedom from this complication was 97% at 
10 years (Fig. 6). 
Fig. 7 presents actuarial freedom from thrombo- 
embolism, a complication that occurred in four 
patients. In one patient thrombus developed on 
a Björk-Shiley valve 10 years after the operation; 
this patient underwent successful composite rere- 
placement with a St. Jude Medical prosthesis. 
Embolic episodes were recorded in three other 
patients; all three patients recovered completely. 
Two of the embolic events were in the setting 
of inadequate anticoagulation. One patient had 
a stroke on the third postoperative day, before 
therapeutic anticoagulation was achieved. The 
second patient had a small stroke when warfarin 
was interrupted for pacemaker placement. The 
rate of thromboembolic events was 0.42 events/100 
patient-years (4 events/962 patient-years of follow- 
up). 
542 Gott et al. 
The Journal of Thoracic and 
Cardiovascular Surgery 
March 1995 
Table Y¢. Univariate and multivariate predictors of 
mortality 
p Value 
Risk factors Univariate Multivariate 
NYHA class 0.0001 0.0001 
Preop dissection 0.0004 0.015 
Non-Marfan 0.0005 0.007 
Male gender 0.024 0.012 
Urgent operation 0.0001 NS 
Age 0.033 NS 
Previous aortic root operation 0.04 NS 
Mitral valve operation 0.32 NS 
Circulatory arrest 0.11 NS 
Era of operation 0.67 NS 
NS, Not significant 
Discussion 
Before 1970, surgical procedures to replace the 
ascending aorta and aortic valve carried high oper- 
ative mortality. Repair typically consisted of re- 
placement of the aortic valve and placement of a 
supracoronary sleeve graft in the ascending aorta, 
frequently on an emergency basis, for acute dissec- 
tion or rupture. In the 10 years before this series 
began, operative mortality for such a procedure at 
our institution approached 60%. After the initial use 
of the Bentall composite graft procedure at out 
institution in 1976, our operative results improved 
dramatically, as they did elsewhere. Thirty-day mor- 
tality for aortic root replacement has fallen below 
5% in this report and others. 2-4' lo These results are 
gratifying given the high mortality attending un- 
treated ascending aortic aneurysm, dissection, and 
root infection. Improved results can be traced to 
growing surgical experience, refinement ofoperative 
technique, and advances in management of anesthe- 
sia, cardiopulmonary bypass, and myocardial protec- 
tion, as well as early surgical intervention before 
aortic catastrophe. 
Although the mortality rate for root replacement 
is low, risk factors for early or late death have been 
identified. We chose to group early and late deaths 
in this analysis because heterogeneity of the patient 
series made separate analysis of early and late 
mortality unnecessarily complex. In this series, poor 
preoperative NYHA functional class, non-Marfan 
status, presence of aortic dissection, and male gen- 
der were predictors of death. Surprisingly, era of 
operation, concomitant mitral valve operation, pre- 
vious aortic root operation, and use of hypothermic 
circulatory arrest were not significant predictors of 
mortality. 
Dissection at the time of root replacement, espe- 
cially type I, was a strong predictor of late mortality. 
Indeed, survival at 10 years in patients with type I 
dissection was only 45%. The presenee of dissection 
not only predicted greater isk of death, but also 
portended late aneurysm and possible aortic rup- 
ture. Given the high mortality and complication rate 
seen in patients with dissection remaining in the 
aorta distal to the composite graft, meticulous man- 
agement of blood pressure by /3-adrenergic block- 
ade and close follow-up imaging of the distal aorta 
are warranted. We recommend an echocardiogram 
6 months after root replacement and annual mag- 
netic resonance imaging of the aorta thereafter. 
Endocarditis remains the most common late com- 
plication after aortic root replacement. Appropriate 
antibiotic prophylaxis remains the mainstay pre- 
ventative measure. Alternate initial surgical ap- 
proaches, such as homograft root replacement and 
pulmonary autograft procedures, may reduce this 
risk further but are unlikely to eliminate it alto- 
gether. Although graft sterilization with antibiotic 
therapy alone was occasionally successful, rereplace- 
ment of the aortic root with a crypopreserved aortic 
homograft was the only reliable and consistently 
successful treatment. 
The rate of thromboembolism in this series was 
strikingly low. We are aware of only four patients 
among 256 hospital survivors with a composite graft 
who had a clinically significant hromboembolism. 
The low thromboembolic rate (0.42 events/100 pa- 
tient-years) is superior to that of isolated Björk- 
Shiley and St. Jude Medical aortic valves, typically 
reported to be 1 event/100 yearsJ 1 Anticoagulation 
management has been identical to that for patients 
with isolated aortic valve replacement. We speculate 
that the lower incidence of thromboembolism may 
relate to the fact that the valve sutures, pledgets, 
knots, and much of the valve sewing ring are ex- 
cluded from the bloodstream in a composite graft, 
but remain exposed in isolated valve replacement. 
In summary, this experience has shown that aortic 
root replacement by means of Bentall's composite 
graft technique (in conjunction with selective use of 
cryopreserved aortic homografts) can be applied 
successfully to a variety of diseases affecting the 
aortic valve and ascending aorta. Operative and late 
mortality have been low. Risk factors for death have 
been identified and include poor preoperative func- 
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Fig. 6. Actuarial freedom from complications in the residual aorta. 
13 14 
tional class, non-Marfan status, presence of aortic 
dissection, and male gender. Concomitant mitral 
operations have not increased operative risk. Endo- 
carditis rernains the most comrnon late cornplication 
and is best treated by root rereplacernent with a 
cryopreserved aortic homograft. Late thrornboem- 
bolisrn has been rare. When dissection is present at 
operation or the distal native aortic tissue is dis- 
eased, careful follow-up of the distal aorta is critical 
to long-terrn survival. 
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Discuss ion 
Dr. C. E. Anagnostopoulos (New York, N.Y.). On the 
basis of these results, do you advocate new early indica- 
tions for doing the operation in the patient with Marfan 
syndrome with annular aortic ectasia, even though the 
aortic valve insufficiency may be only 1+ or 2+, particu- 
larly when there is a recent change in the size of the aorta? 
Would you advo¢ate doing the operation in a patient with 
a 4.5 cm aorta that has changed over the past 6 months? 
Dr. Gott. Ordinarily we would not operate on a 4.5 cm 
aorta. However, the majority of our patients who were 
operated on with a 6 cm root had no aortic insufficiency, 
so the great proportion of these patients were operated on 
prophylactically. 
Dr. Pyeritz has pointed out to me that in patients with 
a family history of dissection, we need to move ahead at 
5 cm. Four or five patients in the group have had 
dissection at 5.5 cm. 
If we were operating to correct mitral regurgitation i  a 
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patient with a 4.5 cm aorta, we would certainly perform 
root replacement, 
Dr. Hans G. Botst (Hannover, Gerrnany). We noted that 
the early mortality in patients with disseetions was sub- 
stantially greater than in patients with aneurysms. Did you 
include chronic dissections in your report? 
Dr. Gott. About two thirds of the 41 patients with 
Marfan syndrome had chronic dissections and one third 
had acute dissections. 
Dr. Botst. Why do you think that the risk in chronic 
dissection was substantially greater? We do not find that 
to be true. In our experienee, there is a big difference in 
the operative risk of acute versus chronic cases. 
Dr. Gott. I think a couple of late deaths occurred in 
patients with chronic dissection as a result of a problem 
with the part of the aorta that was not operated on. That 
may explain the difference, but I do not have a good 
explanation. 
Dr. Borst. Your study gives the opportunity to assess 
Bentalrs original method once again. Some physicians 
have been very worried about wrapping the ascending 
aorta in terms of a possible perigraft hematoma nd a 
perfused perigraft space. Inasmuch as you have done so 
many of the original Bentall operations, I wonder how 
often you have seen these complications and whether you 
consider them to be a major problem. 
Dr. Gott. We used the wrap until 1988, when Dr. 
Kouchoukos published his paper, and we stopped using 
the wrap after that. We have had six coronary dehiscences, 
with fortunately only one late death at 7 years; the other 
five have been successfully repaired. We no longer wrap 
the graft tightly. We merely lay the residual aortic wall on 
the graft. 
Dr. Botst. I think this is a very important notion. When 
discussing these complications, it is always interesting to 
know whether the operation was performed by an expe- 
rieneed surgeon. In the former case, the complications 
might be due to the innate shortcomings ofthe procedure; 
in the latter, the operation may not have been properly 
performed. 
Dr. Robert W. M. Frater (New York, N.Y.). You had had 
such an enormous experience of with the Marfan syn- 
drome. I saw a case not so long ago with about a 4.5 cm 
aneurysm, and on the magnetic resonance imaging scan 
was a tiny dissection. The internist following the case said 
we did not have to worry about that. In his words: 
"Marfan's cases always have little bits of dissection here 
and there." 
Dr. Gott. I do not agree. If we see a small dissection in 
a patient with Marfan syndrome, the patient is sent to the 
operating room right away. By contrast, in the patient with 
coronary disease, we can observe that type of dissection. 
